Echo Street Capital Management LLC Novo Cure LTD Transaction History

Echo Street Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$56.6 - $89.9 $163,008 - $258,912	2,880 New	2,880 $200,000
Q4 2021 Feb 14, 2022	SELL	$75.08 - $121.99 $148,283 - $240,930	-1,975 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$116.17 - $194.55 $48,907 - $81,905	421 Added 27.09%	1,975 $229,000
Q2 2021 Aug 16, 2021	BUY	$130.4 - $225.58 $202,641 - $350,551	1,554 New	1,554 $345,000
Q1 2021 May 17, 2021	SELL	$124.11 - $190.17 $747,762 - $1.15 Million	-6,025 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$112.16 - $174.14 $675,764 - $1.05 Million	6,025 New	6,025 $1.04 Million

263

77M

1.17M

318K

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $3.37B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

Get notified when there are updates to the investment portfolio of Echo Street Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Echo Street Capital Management LLC with notifications on news.